News
NANOBIOTIX Selected to Enter Euronext’s Tech 40 Label
PARIS& CAMBRIDGE, Mass.---- Regulatory News:. NANOBIOTIX, a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced that it has been selected to enter the Euronext’ s Tech40 label, recognizing the best performing Tech SMEs listed on Euronext markets. Companies within the Tech 40 label are technology stocks...
PARIS& CAMBRIDGE, Mass.---- Regulatory News:. NANOBIOTIX, a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced that it has been selected to enter the Euronext’ s Tech40 label, recognizing the best performing Tech SMEs listed on Euronext markets. Companies within the Tech 40 label are technology stocks...